Sotrovimab Expanded Access Treatment Protocol (COVID-19)

Summary

An expanded access program for sotrovimab administered intravenously to participants with COVID-19 illness who meet current authorized/approved criteria for use of sotrovimab.

Timeline

Start

—

Primary completion

—

Completion

—

Drugs

Indications